Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Current Assets (2019 - 2025)

Biodesix's Current Assets history spans 7 years, with the latest figure at $32.5 million for Q4 2025.

  • For Q4 2025, Current Assets fell 17.64% year-over-year to $32.5 million; the TTM value through Dec 2025 reached $32.5 million, down 17.64%, while the annual FY2025 figure was $32.5 million, 17.64% down from the prior year.
  • Current Assets reached $32.5 million in Q4 2025 per BDSX's latest filing, down from $33.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $81.2 million in Q1 2021 to a low of $24.1 million in Q3 2022.
  • Average Current Assets over 5 years is $40.8 million, with a median of $34.9 million recorded in 2022.
  • Peak YoY movement for Current Assets: surged 211.01% in 2021, then tumbled 66.48% in 2022.
  • A 5-year view of Current Assets shows it stood at $43.6 million in 2021, then rose by 22.29% to $53.3 million in 2022, then dropped by 25.6% to $39.7 million in 2023, then decreased by 0.5% to $39.5 million in 2024, then dropped by 17.64% to $32.5 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Current Assets are $32.5 million (Q4 2025), $33.4 million (Q3 2025), and $32.4 million (Q2 2025).